menu
    • menu

    Company profile for EffRx Pharmaceuticals

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    EffRx Pharmaceuticals is a commercial-stage pharmaceutical company focused on the late-stage development and commercialization of prescription medications for niche and orphan indications. The business model is centered around providing superior clinical and commercial value propositions for physicians, payers and patients. EffRx pro-actively seeks in-licensing opportunities for Europe in niche therapeutic areas, with a primar...
    EffRx Pharmaceuticals is a commercial-stage pharmaceutical company focused on the late-stage development and commercialization of prescription medications for niche and orphan indications. The business model is centered around providing superior clinical and commercial value propositions for physicians, payers and patients. EffRx pro-actively seeks in-licensing opportunities for Europe in niche therapeutic areas, with a primary interest for rare diseases, where EffRx has received an orphan drug designation (ODD) from the FDA for the treatment of adolescent PCOS.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    EffRx PharmaceuticalsSwitzerland Flag
    Country
    Country
    Switzerland
    Address
    Address
    Wolleraustrasse 41B 8807 Freienbach
    Telephone
    Telephone
    +41 44 503 78 60
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.effrx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/effrx-pharmaceuticals-sa
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/effrx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    EffRx Pharmaceuticals Signs Exclusive Licensing Agreement With Radius Health
    EffRx Pharmaceuticals Signs Exclusive Licensing Agreement With Radius Health

    19 Sep 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230919375524/en

    BUSINESSWIRE
    19 Sep 2023
    Share Share
    Abiogen Pharma completes the acquisition of EffRx Pharmaceuticals
    Abiogen Pharma completes the acquisition of EffRx Pharmaceuticals

    30 May 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/abiogen-pharma-completes-the-acquisition-of-effrx-301833815.html

    PR NEWSWIRE
    30 May 2023
    Share Share
    World Orphan Drug Alliance – partnering with Decisive Consulting to broaden
    World Orphan Drug Alliance – partnering with Decisive Consulting to broaden

    14 Nov 2022

    // PRNEWSWIRE

    https://www.biospace.com/article/world-orphan-drug-alliance-partnering-with-decisive-consulting-to-broaden-access-capability/

    PRNEWSWIRE
    14 Nov 2022
    Share Share
    WODA combining forces to reach patients with rare diseases across globe
    WODA combining forces to reach patients with rare diseases across globe

    13 May 2022

    // BIOSPECTRUMASIA

    https://www.biospectrumasia.com/news/25/20290/woda-combining-forces-to-reach-patients-with-rare-diseases-across-globe.html

    BIOSPECTRUMASIA
    13 May 2022
    Share Share
    EffRx Pharma Signs Exclusive License Agreement With Diurnal
    EffRx Pharma Signs Exclusive License Agreement With Diurnal

    26 Apr 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220426005645/en

    BUSINESSWIRE
    26 Apr 2022
    Share Share
    EffRx Obtains Swiss Marketing Authorization for Alkindi
    EffRx Obtains Swiss Marketing Authorization for Alkindi

    16 Nov 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211116005774/en

    BUSINESSWIRE
    16 Nov 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search